首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備感染疾病動物用醫藥

市場調查報告書

商品編碼

1775452

全球動物感染疾病診斷市場：2025年至2030年預測

Global Veterinary Infectious Diseases Diagnostics Market - Forecasts from 2025 to 2030

出版日期: 2025年06月27日 | 出版商:

Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

動物感染疾病診斷市場預計將從 2025 年的 27.95 億美元成長到 2030 年的 41.24 億美元，複合年成長率為 8.09%。

感染疾病率上升

伴侶動物和牲畜感染疾病率的上升是市場擴張的主要驅動力。其中包括狂犬病在內的人畜共患疾病每年導致數萬人死亡（根據世界衛生組織統計，99% 的人類感染疾病與狗有關）和通用，由於動物環境中不良的衛生習慣加劇了細菌、病毒和寄生蟲感染而呈上升趨勢。例如，狂犬病在 150 多個國家流行，每年造成經濟約 86 億美元的損失，亞洲和非洲受到的影響最大。通用易受疾病感染，五分之一的牲畜死於嚴重感染疾病，造成全球整體約 800 億美元的經濟損失。這凸顯了定期診斷檢測對於確保牲畜健康和防止疾病傳播的重要性，特別是對於構成公共衛生風險的人畜共通感染疾病。禽流感等疾病進一步加劇了早期發現的迫切性，2023 年全球報告的疫情超過 3,500 起。

對動物健康的需求不斷增加

牲畜對糧食安全、營養和經濟成長至關重要，但感染疾病威脅牲畜生產力以及肉類、家禽和乳製品等畜產品的品質。不衛生的環境，例如受污染的水源和飼料，會滋生細菌和寄生蟲，加劇疾病的傳播。這導致對獸醫診斷的需求日益成長，以降低風險並確保牲畜健康，這對於維持農業經濟和滿足全球糧食需求至關重要。

技術進步

診斷技術的進步正在改變市場，使疾病檢測更快、更準確。 2024 年 9 月，碩騰推出了 Vetscan OptiCell，這是一款基於人工智慧的墨盒式血液學分析儀，用於即時全血細胞計數 (CBC) 分析。此外，碩騰還推出了 Stablelab，這是一款手持式照護現場血液檢測儀，可在 10 分鐘內透過血清澱粉樣蛋白 A (SAA) 水平檢測馬匹的炎症，使獸醫能夠在症狀出現之前識別感染疾病。 ProSolit 的牛病毒 3 血清學診斷 ELISA套件可快速可靠地檢測牛血漿、血漿和牛奶，提高牲畜的診斷準確性。 2024 年 2 月，MiDOG Animal Diagnostics 推出了一種一體化診斷測試，可快速檢測多種動物的細菌和真菌感染疾病（包括抗生素抗藥性），以基於分子的診斷方法取代傳統方法。這些技術創新反映了照護現場和分子診斷的趨勢，推動了治療效果的改善和市場的成長。

市場區隔分析

分子診斷

分子診斷領域預計將實現顯著成長，這得益於其高靈敏度、快速結果以及在研究中心和診斷實驗室的日益普及。即時PCR和多重PCR等技術，如碩騰VetScan Flex4等產品，能夠準確檢測感染疾病、遺傳性疾病和基因組突變，進而監測治療效果。牲畜和伴侶動物疾病的複雜性和流行程度日益增加，促使飼主選擇這些先進的檢測方法，從而在預測期內提升市場佔有率。

農場動物

由於感染疾病的高疾病負擔和經濟影響，畜牧業預計將佔據顯著的市場佔有率。定期診斷監測牛結核病、豬瘟和禽流感等疾病對於維護牛健康和確保食品安全至關重要。例如，在碩騰公司於2023年8月推出的Vetscan Mastigram+的支援下，定期對乳牛進行乳房炎篩檢，有助於提高牛奶品質和牛生產力。政府舉措將進一步推動該領域的成長，例如印度將在2023年「印度製造」計畫下開發藍舌病夾心ELISA試劑套件和日本腦炎IgM ELISA試劑盒。

區域洞察

到2024年，北美將佔據38%的市場佔有率，這得益於先進的獸醫基礎設施、高寵物擁有率（到2025年，美國將有9,400萬個家庭擁有寵物）以及巨額的醫療費用支出。預計亞太地區將成長最快，這得益於人們對通用感染疾病的認知不斷提高、寵物擁有率不斷上升以及政府對動物健康的支持，尤其是在印度和中國等國家。

市場挑戰

挑戰包括先進診斷檢測的高成本以及新興市場熟練獸醫的短缺，這可能會限制其應用。此外，惡劣的環境加劇了疾病的傳播，因此需要持續投資於診斷和基礎設施。

結論

預計到2028年，動物感染疾病診斷市場將迎來強勁成長，這得益於感染疾病盛行率的上升，尤其是通用和家畜感染疾病，以及分子診斷和照護現場診斷技術的進步。碩騰和Prosolit等主要企業的技術創新，以及對牲畜健康管理需求的不斷成長，是關鍵的催化劑。北美和亞太地區引領著區域成長，但必須策略性地應對成本和技術短缺等挑戰，才能保持市場動能。

本報告的主要優點

深刻分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
競爭格局：了解主要企業採用的策略策略，並了解正確策略的市場滲透潛力。
市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
可行的建議：利用洞察力來提供策略決策，在動態環境中開闢新的業務流和收益。
受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業來說，都是有益且具有成本效益的。

它有什麼用途？

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

2022 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
競爭定位、策略和市場佔有率分析
收益成長和預測細分市場和區域分析（包括國家）
公司概況（尤其是財務狀況和關鍵發展）

The growing incidence of infectious diseases in both companion and livestock animals is a primary driver of market expansion. Zoonotic diseases, including rabies, which causes tens of thousands of deaths annually (with 99% of human cases linked to dogs, per WHO), and canine distemper, are increasing due to bacterial, viral, and parasitic infections exacerbated by poor hygiene practices in animal environments. For instance, rabies, prevalent in over 150 countries, imposes an economic burden of approximately US$8.6 billion annually, with significant impacts in Asia and Africa. Livestock animals face high disease susceptibility, with one in five farm animals lost to serious infections, leading to global economic losses of around US$80 billion. This underscores the critical need for regular diagnostic checkups to ensure animal health and prevent disease transmission, particularly for zoonotic diseases that pose public health risks. The urgency for early detection is further amplified by diseases like avian influenza, with over 3,500 outbreaks reported globally in 2023, highlighting the need for robust diagnostics.

Growing Demand for Livestock Health

Livestock animals are vital for food security, nutrition, and economic growth, yet infectious diseases threaten their productivity and the quality of animal-derived products like meat, poultry, and dairy. Unhygienic conditions, such as contaminated water sources and feed, foster the growth of bacteria and parasites, increasing disease prevalence. This drives demand for veterinary diagnostics to mitigate risks and ensure the health of livestock, which is critical for sustaining agricultural economies and meeting global food demands.

Technological Advancements

Advancements in diagnostic technologies are transforming the market by enabling faster, more accurate disease detection. In September 2024, Zoetis launched Vetscan OptiCell, an AI-powered, cartridge-based hematology analyzer for point-of-care complete blood count (CBC) analysis, offering lab-quality results with enhanced efficiency. Additionally, Zoetis introduced the Stablelab handheld device, a point-of-care blood test that detects equine inflammation via Serum Amyloid A (SAA) levels within 10 minutes, allowing veterinarians to identify infections before symptoms appear. Prosolit's ELISA kit for serodiagnosis of Bovine Adenovirus 3 provides rapid, reliable testing for cattle, targeting blood sera, plasma, and milk, enhancing diagnostic accuracy for livestock. In February 2024, MiDOG Animal Diagnostics introduced an All-in-One Diagnostic Test for rapid detection of bacterial and fungal infections, including antibiotic resistance, across various animal species, replacing traditional methods with molecular-based diagnostics. These innovations reflect a trend toward point-of-care and molecular diagnostics, improving treatment outcomes and driving market growth.

Market Segmentation Analysis

Molecular Diagnostics

The molecular diagnostics segment is poised for significant growth due to its high sensitivity, rapid results, and increasing adoption in research centers and diagnostic laboratories. Techniques like real-time PCR and multiplex PCR, as seen in products like Zoetis' VetScan Flex4, enable precise detection of genomic variants for infectious diseases, genetic disorders, and therapy monitoring. The complexity and rising prevalence of diseases in livestock and companion animals are encouraging owners to opt for these advanced tests, boosting their market share over the forecast period.

Livestock Animals

The livestock segment is expected to hold a notable market share, driven by the high disease burden and economic implications of infections. The need for routine diagnostics to monitor diseases like bovine tuberculosis, swine fever, and avian influenza is critical for maintaining herd health and ensuring food safety. For instance, regular mastitis screening in dairy cattle, supported by Zoetis' Vetscan Mastigram+ launched in August 2023, enhances milk quality and herd productivity. The segment's growth is further fueled by government initiatives, such as India's development of Bluetongue Sandwich ELISA and Japanese Encephalitis IgM ELISA kits under the "Make in India" program in 2023.

Regional Insights

North America dominates the market with a 38% share in 2024, driven by advanced veterinary infrastructure, high pet ownership (94 million U.S. households with pets in 2025), and significant health expenditure. The Asia-Pacific region is the fastest-growing, propelled by rising zoonotic disease awareness, increasing pet adoption, and government support for animal health, particularly in countries like India and China.

Market Challenges

Challenges include the high cost of advanced diagnostic tests and a shortage of skilled veterinarians in emerging markets, which may limit adoption. Additionally, ensuring hygiene in livestock environments remains a hurdle, as poor conditions exacerbate disease spread, necessitating ongoing investment in diagnostics and infrastructure.

Conclusion

The veterinary infectious disease diagnostics market is set for robust growth through 2028, driven by rising disease prevalence, particularly zoonotic and livestock infections, and advancements in molecular and point-of-care diagnostics. Innovations from key players like Zoetis and Prosolit, alongside growing demand for livestock health management, are key catalysts. North America and Asia-Pacific lead regional growth, though challenges like cost and skill shortages require strategic solutions to sustain market momentum.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Technology Type

Immunodiagnostics
Molecular Diagnostics
Hematology
Urinalysis
Others

By Pathogen Type

Virus
Bacteria
Parasite
Others

By Animal Type

Companion Animal
Cats
Dogs
Horse
Others
Livestock
Cattle
Swine
Sheep
Others

By End-User

Diagnostics Laboratories
Veterinary Clinics
Research Centers

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
UK
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY TECHNOLOGY TYPE

5.1. Introduction
5.2. Immunodiagnostics
5.3. Molecular Diagnostics
5.4. Hematology
5.5. Urinalysis
5.6. Others

6. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY PATHOGEN TYPE

6.1. Introduction
6.2. Virus
6.3. Bacteria
6.4. Parasite
6.5. Others

7. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY ANIMAL TYPE

7.1. Introduction
7.2. Companion Animal
- 7.2.1. Cats
- 7.2.2. Dogs
- 7.2.3. Horse
- 7.2.4. Others
7.3. Livestock
- 7.3.1. Cattle
- 7.3.2. Swine
- 7.3.3. Sheep
- 7.3.4. Others

8. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY END-USER

8.1. Introduction
8.2. Diagnostics Laboratories
8.3. Veterinary Clinics
8.4. Research Centers

9. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY GEOGRAPHY

9.1. Introduction
9.2. North America
- 9.2.1. USA
- 9.2.2. Canada
- 9.2.3. Mexico
9.3. South America
- 9.3.1. Brazil
- 9.3.2. Argentina
- 9.3.3. Others
9.4. Europe
- 9.4.1. Germany
- 9.4.2. France
- 9.4.3. United Kingdom
- 9.4.4. Spain
- 9.4.5. Italy
- 9.4.6. Others
9.5. Middle East and Africa
- 9.5.1. Saudi Arabia
- 9.5.2. UAE
- 9.5.3. Others
9.6. Asia Pacific
- 9.6.1. China
- 9.6.2. India
- 9.6.3. Japan
- 9.6.4. Australia
- 9.6.5. Others